C2ORF47 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
6.11732886568461E-14 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
1.618840E-01 |
Stage1-vs-Stage3 |
1.763030E-04 |
Stage1-vs-Stage4 |
7.75849999999911E-05 |
Stage2-vs-Stage3 |
2.235800E-01 |
Stage2-vs-Stage4 |
1.076030E-01 |
Stage3-vs-Stage4 |
6.428200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.62492241884138E-12 |
Normal-vs-Asian |
4.85760000001889E-06 |
Caucasian-vs-AfricanAmerican |
7.118400E-01 |
Caucasian-vs-Asian |
6.406000E-01 |
AfricanAmerican-vs-Asian |
7.348800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.79856129989275E-13 |
Male-vs-Female |
5.96250004925025E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.69553260320754E-12 |
Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(81-100Yrs) |
8.45070000000669E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.614210E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.863700E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.730420E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.526400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.161200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.039800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.0991000038737E-08 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
8.798000E-01 |
Grade 1-vs-Grade 3 |
7.481800E-02 |
Grade 1-vs-Grade 4 |
1.959640E-04 |
Grade 2-vs-Grade 3 |
5.619900E-03 |
Grade 2-vs-Grade 4 |
6.1482000046631E-08 |
Grade 3-vs-Grade 4 |
5.632500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.66766600528945E-12 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
1.08357767203415E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62458935193399E-12 |
Normal-vs-N1 |
5.88260551381836E-11 |
N0-vs-N1 |
9.476200E-02 |
|
|